Contrast and imaging agents in interventional X-ray market plays an important role in improving the health-related issues in the healthcare sector. Contrast material, which is also known as contrast agents or contrast media, is used to improve image quality produced by X-rays, computed tomography (CT) and other imaging techniques. By using contrast materials radiologists can distinguish normal from abnormal conditions within the body.
Contrast agents or media doesn’t permanently discolour internal organs. Prior to the imaging exam, when the contrast agent is introduced in the body, these contrast materials forms some shape in the body which helps to appear different than that if no contrast agent is administered. Contrast agents or media help physicians diagnose medical conditions by improving the vision. The material is absorbed by the body or eliminated through urine or bowel movements. There are various ways to use contrast material such as swallowed (taken by mouth or orally), injected into a blood vessel (vein or artery; also called given intravenously or intra-arterially) and administered by enema (given rectally). Different types of contrast materials are available including Iodine-based and barium-sulphate compounds used majorly in X ray and CT, Gadolinium which is used in magnetic resonance (MR) imaging and many others.
Global contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 5.6% in the forecast period 2019 to 2026.
Read More:
https://databridgemarketresearch.com/reports/global-contrast-and-imaging-agents-in-interventional-x-ray-market/
Segmentation: Global Contrast and Imaging Agents in Interventional X-ray Market
Global contrast and imaging agents in interventional X-ray market is categorized into three segments which are agent type, application and end user.
- On the basis of agent type, the market is segmented into iodinated contrast media, barium-based contrast media, microbubble contrast media, gold nanoparticle contrast agents and others. In 2019, iodinated contrast media segment is expected to dominate the market share and expected to grow with the highest CAGR in the forecast period of 2019 to 2026.
- In March 2017, GE Healthcare expanded its MRI contrast media product portfolio by launching a macrocyclic agent named Clariscan in Asia Pacific. This strategy helped the company to enhance its customer base and also expand their product portfolio.
click on the link to view details:
https://databridgemarketresearch.com/reports/global-contrast-and-imaging-agents-in-interventional-x-ray-market/
Competitive Analysis: Global Contrast and Imaging Agents in Interventional X-ray Market
Some of the major players operating in this market are General Electric Company, Bracco, Lantheus Medical Imaging, Inc., Guerbet, FUJIFILM VisualSonics Inc, Jodas Expoim, TAEJOON PHARM, Unijules Life Sciences Ltd., J.B.Chemicals & Pharmaceuticals Ltd., iMAX, Novalek Pharmaceuticals Pvt. Ltd., Nano Therapeutics Pvt Ltd and among others.
Contact:
Customer Support 24*7
USA Number – +1 888 387 2818 (Toll – Free)
Europe Number – +44 208 089 1725
Asia Pacific Number – +81 34 520 8959
Skype.Address: databridgemarketresearch
databridgemarketresearch 